Dominik Selleslag

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

John Rex, Ben de Pauw, John E. Bennett et al. · Clinical Infectious Diseases · 2002 · 2.3K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Hervé Dombret, John F. Seymour, Aleksandra Butrym et al. · Blood · 2015 · 1.1K citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +2

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Johan Maertens, Issam Raad, Kieren A. Marr et al. · The Lancet · 2015 · 972 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

Luca Malcovati, Eva Hellström‐Lindberg, David Bowen et al. · Blood · 2013 · 667 citations · Full text

Medicine, Hematology, Oncology +13

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

J. Maertens, Issam Raad, G. Petrikkos et al. · Clinical Infectious Diseases · 2004 · 662 citations · Full text

Medicine, Microbiology, Pharmacology +17